Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 22, 1999

View Archived Issues

Strong growth continues for Roche during Q3 1999

Immunex continues Enbrel research during Q3; sBLA filed for additional indication

GelTex files for FDA approval of two products during Q3 1999

AEterna steps up AE-941/Neovastat development

Cell Pathways files first NDA during Q3 1999

Preclinical data for FTY-720 presented at recent Japanese meetings

Wyeth is first to cross the finish line with meningococcal group C conjugate vaccine

Biogen places anti-CD40 ligand MAb studies on hold

Orally active inhibitors of rhinoviral replication discovered at Lilly

AstraZeneca files first application for improved PPI

Development of potential new antiaddictive agent supported by NIDA

Development status update for antiglaucoma drug candidate

Q3 1999 at Amgen sees new product in phase III

Breast cancer patients now being sought for Korean trials of Genexol

Inhale acquires novel particle formulation technology for lung delivery

Approval recommended for Bayer's Avelox

SB reports temporary setback in European launch of Avandia

Approvable letter voices FDA concerns about safety of Ergoset; Ergo Science to study options

Anti-HIV pseudopeptide has a unique mechanism of action

Another major milestone announced for Wyeth Lederle Vaccines' pneumococcal vaccine

Korean investigators identify potent anti-HSV agent from natural source

Canadian approval sought for new anti-HBV product

Mechanistically novel iNOS inhibitors identified during Pharmacopeia/Berlex joint project

Phase I pharmacokinetic, pharmacodynamic and toxicological data published for ISIS-5132

FDA okays new antipsoriatic for clinical testing

Bradykinin antagonist NPC-18884 effective in various rodent models of nociception, edema

Orally active DPP-IV inhibitor presented at EASD meeting heads for clinic

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...